| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-07 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |